纳米药物用于逆转肝细胞癌的免疫抑制微环境

Xier Pan1, Shuting Ni2, Kaili Hu3

  • 1School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China; Shanghai Frontiers Science Center of TCM Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.

Biomaterials
|January 29, 2024
PubMed
概括

纳米药物提供了一个有希望的策略,通过逆转瘤免疫抑制微环境 (TIME) 来克服肝细胞癌 (HCC) 免疫疗法的挑战. 这些方法增强T细胞活性,降低毒性,改善HCC治疗结果.